Stay updated on Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.

Latest updates to the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page
- Check5 days agoChange DetectedRevision notes updated to include v3.4.3 and remove v3.4.2.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2 to the site. The prior 3.4.1 notice about government funding and operating status was removed, indicating an update to the page template.SummaryDifference0.4%

- Check41 days agoChange DetectedA government funding status notice was added to the page. The page revision was updated to v3.4.1, replacing the previous v3.4.0 reference.SummaryDifference0.4%

- Check48 days agoChange DetectedThe glossary toggle is now available, and a 'Last Update Submitted that Met QC Criteria' label was added in the updates section along with a 'No FEAR Act Data' notice and a revised page version of 'Revision: v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedSite revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedA new Locations section appears with New South Wales and Victoria entries, and the old NSW/Victoria location blocks are removed.SummaryDifference0.3%

Stay in the know with updates to Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.